The company’s secure portal enables patients to schedule appointments, receive automated appointment reminders and provide feedback to their practitioners.
The number of new patients using 1st Group’s appointment booking platform on a monthly basis has surged 700% since 2015.
Presently, almost 60% of all appointments on the platform are made during business hours, up from 48% just two years ago.
This validates 1st Group’s value proposition to practices of making reception desks more efficient, reducing practice administration costs and driving greater convenience for patients.
1ST Group’s first half of FY17 laid the foundations for a potentially stronger revenue and sales growth in the second half, securing major deals with Alphapharm and ProVision in Q2 2017.
Alphapharm, a wholly owned subsidiary of Mylan N.V., is one of the world's leading global pharmaceutical companies.
Customers of Alphapharm’s 410 stores will be able to use 1stAvailable portal and book online services such as flu shots, diabetes and other healthcare services.
There are significant growth opportunities in 2017, following the shift in consumer trends and increasing government initiatives in digitising healthcare such as the launch of the Australian Digital Health Agency in 2016.
1ST Group’s shares were last trading 4.26% higher intra-day on Monday, at $0.049.